Anduril Doubles Valuation to $61B in Largest Defense Tech Private Round

By Premier Alternatives Research
Anduril Doubles Valuation to $61B in Largest Defense Tech Private Round

Anduril Closes $5 Billion Series H

Anduril Industries closed a $5 billion Series H on May 13, 2026, more than doubling its valuation from $30.5 billion to $61 billion in just 12 months. It's the largest private funding round in defense technology history.


Transaction Details

DetailValue
RoundSeries H
Amount Raised$5B
Valuation$61B (up from $30.5B)
Lead InvestorsThrive Capital, Andreessen Horowitz
Total Raised$11B+

Business Highlights

  • 2025 Revenue: $2.2B (doubled YoY)
  • Workforce: Nearly doubled in 2025
  • Core Products: Lattice (autonomous command platform), Ghost (autonomous drones), Menace (counter-drone), Arsenal (manufacturing)
  • Key Contracts: U.S. Department of Defense, allied nations

IPO Outlook

Founder Palmer Luckey has stated Anduril will IPO "in the next few years" but wants to reach profitability first. No S-1 has been filed. The company is focused on scaling production at its new manufacturing facilities.


What This Means for Secondary Market Holders

The 2x valuation jump in 12 months represents significant appreciation for early secondary buyers. Key considerations:

  • New price floor: $61B resets the mark for all secondary transactions
  • No near-term IPO: Creates a window for secondary market activity at the new valuation
  • Defense spending tailwinds: Bipartisan support for defense modernization continues to drive growth
  • Revenue trajectory: Doubling revenue annually with expanding margins

Sources: TechCrunch, CNBC

Premier Alternatives is a registered agent of Rainmaker Securities, LLC, a FINRA registered broker-dealer and SIPC member. This article is for informational purposes only and does not constitute an offer or solicitation to buy or sell securities.

Looking for secondary liquidity options?

Our team specializes in creating tailored solutions for late-stage private equity holdings. Schedule a confidential consultation to discuss your unique situation.

Discuss Your Options

Confidential, no-obligation consultation

Premier Alternatives Research